Ad
related to: chemotherapy monitoring chart for cancer research foundation bcrf patient- What is Immunotherapy?
Unleash the power of the immune
system to fight cancer.
- Why Donate?
We can change the way cancer is
treated and cured. Make an impact.
- Make A Sustained Impact
Donate a small amount every month
to support ongoing cancer research.
- Ways to Give Back
Donate, fundraise, shop, or match.
Make a charitable bequest, registry
- What is Immunotherapy?
Search results
Results From The WOW.Com Content Network
The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. [1] BCRF currently funds over 255 researchers in 14 countries. [2]
A chemotherapy regimen is a regimen for chemotherapy, defining the drugs to be used, their dosage, the frequency and duration of treatments, and other considerations. In modern oncology, many regimens combine several chemotherapy drugs in combination chemotherapy. The majority of drugs used in cancer chemotherapy are cytostatic, many via ...
Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy (surgery and radiotherapy) and systemic treatment (chemo-, endocrine, and targeted therapies).
Komen works on patient navigation and advocacy, providing resources for breast-cancer patients to understand the American medical system. [5] They have funded research into the causes and treatment of breast cancer. [6] However, the organization has been mired by controversy over pinkwashing, allocation of research funding, and CEO pay. The ...
While it is no longer considered the most efficient all-around chemotherapy, it retains a great importance in the treatment of elderly patients with luminal cancers and may become important for the treatment of estrogen receptor negative androgen receptor positive luminal (GATA3 expressing) breast cancer.
Nutritional problems are also frequently seen in cancer patients at diagnosis and through chemotherapy treatment. Research suggests that in children and young people undergoing cancer treatment, parenteral nutrition may help with this leading to weight gain and increased calorie and protein intake, when compared to enteral nutrition.
stem cell transplant, e.g. marrow transplant. This allows more intensive chemotherapy to be given, and in addition the transplanted bone marrow may help eradicate the minimal residual disease; immunotherapy; monitoring the patient carefully for early signs of relapse. This is an area of active research in several countries.
ICE in the context of chemotherapy is an acronym for one of the chemotherapy regimens, used in salvage treatment of relapsed or refractory non-Hodgkin's lymphoma and Hodgkin lymphoma. In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE.